Discover Thomson Reuters
May 31 - Jeffrey Goldfarb and Robert Cyran discuss how a new SARS-like affliction highlights the differences in the intellectual property fights in the pharmaceuticals and technology industries.
03:23
02:28
00:46
01:41
00:44
01:02
01:50
00:28
01:59
01:36
02:25
01:47
02:36
02:21
02:10
01:17
01:14
00:51
03:08
01:21
01:45